2 terminated, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Deoxyglucose: new trials by email Literature Review of Deoxyglucose trials Research Report on Deoxyglucose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults 2-Deoxy-D-glucose, Placebo - Acute Nasopharyngitis | Phase 2 | Terminated | G.ST Antivirals GmbH | 64 | 2024-04-02 | 2024-11-19 |
| Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy Oral 2-Deoxy-D-Glucose (2DG) - Epilepsy; Seizure | Phase 2 | Completed | University of Virginia | 9 | 2022-09-02 | 2026-06-09 |
| A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer 2-deoxyglucose - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Rutgers, The State University of New Jersey | 12 | 2006-11-01 | 2023-12-22 |
Common Cold (1) · Epilepsy (1) · Prostatic Neoplasms (1)
G.ST Antivirals GmbH (1) · Rutgers, The State University of New Jersey (1) · University of Virginia (1)
United States (2) · Netherlands (1)
Ingrid de Visser-Kamerling, PhD (1) · Nathan B Fountain, MD (1) · Robert DiPaola, MD (1)